Skip to main navigation
Telix Pharmaceuticals Limited Logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Financials
    • Half-year & Quarterly Results
    • Annual Reports & AGMs
    • ASX Announcements
    • SEC Filings
  • Pipeline
  • Stock
    • Stock Quote & Chart
    • Analyst Coverage
  • Corporate Governance
    • Board & Management
    • Documents & Charters
    • Sustainability
  • Resources
    • Shareholder Information
    • Investor Resources
    • Email Alerts
    • Contact Us

Investors

Telix is a biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies.

Minimum 15 minutes delayed. Source: LSEG

Show all

Latest Results | H1 2026

  • Results Release
  • Interim Report
  • Webcast

Events

22 Sep 2026 from 8:30 AM to 12:30 PM EDT
Telix 2026 R&D Day 2026 (New York City)
15 Sep 2026 10:30 AM EDT
H.C. Wainwright 28th Annual Global Investment Conference
14 Sep 2026 9:15 AM EDT
Morgan Stanley 24th Annual Global Healthcare Conference
19 Aug 2026 7:00 PM EDT
Telix H1 2026 Results Webcast
29 Jun 2026 5:00 PM EDT
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
  • All Events

 

Presentations

H1 2026 Results Presentation
  • All Presentations

News

01 Sep 2026
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
02 Sep 2026
Telix Completes Enrollment in Phase 3 BiPASS Study
01 Sep 2026
Telix Appoints David Gill as Chair
19 Aug 2026
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
20 Aug 2026
Telix HY26 Results Presentation
  • All News Releases

Subscribe to our Email Alerts

©2026 Telix Pharmaceuticals Limited.

The Telix Pharmaceuticals and the Illuccix name and logo are trademarks of Telix Pharmaceuticals Limited and its affiliates – all rights reserved. This website is intended for corporate communication and investor relations purposes only and is not intended as promotion or advertising to any audience in any country worldwide.

Privacy Policy. Terms of Use. Cookies Policy. Forward Looking Statements
  • Twitter
  • LinkedIn
  • Facebook
  • YouTube
Search Investors